| abstract |
Disclosed are the use of a compound as shown in general formula I, and an isomer, or pharmaceutically acceptable salt thereof in the preparation of a pharmaceutical composition for treating and/or preventing altitude sickness. The altitude sickness is selected from acute altitude sickness or chronic altitude sickness caused by a high altitude environment of at least 2,000 m above sea level. |